Marksans Pharma has informed that the Company has received intimation from Registrar and Transfer Agent, Bigshare Services on April 08, 2024 regarding the duplicate share certificates of the Company that have been issued, the details of which are enclosed. Name of Shareholder: Yogesh Anand; Folio Y001026. Pursuant to the SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022 a letter of confirmation will be issued to the securities holder / claimant upon completion of necessary procedures regarding duplicate share certificates.
The above information is a part of company’s filings submitted to BSE.
